MedGenome

Servier India launches subsidised biomarker tests for rare cancers

Servier India has tied up with MedGenome and Reliance-backed Strand Life Sciences to offer low-cost IDH1 and IDH2 biomarker testing for rare cancers like AML and CCA across India

Updated On: 12 Nov 2025 | 1:56 AM IST

IFC invests $16.5 mn in MedGenome to increase Covid-19 testing in India

International Finance Corporation, member of the World Bank Group, is investing $16.5 million in genetic diagnostics and research company MedGenome to increase access to Covid-19 testing in India

Updated On: 15 Jul 2021 | 12:55 PM IST

LeapFrog leads $55 mn investment round in Sequoia-backed MedGenome

This investment will be utilised to expand the clinical genomic testing market by expanding access in Tier-II and Tier-III towns and cities across India

Updated On: 02 Apr 2020 | 3:23 AM IST

MedGenome offers research and diagnostics in complex gene-related maladies

Genomics is the study of genes and its functions that help identify their combined influence on growth and development of the organism

Updated On: 25 Mar 2018 | 10:19 PM IST